Schumer To Force Senate GOP To Vote On Three-Year Extension Of Health Insurance Subsidies

Senate Democratic Leader Chuck Schumer (N.Y.) announced Thursday that Democrats will force Republican senators to vote next week on a three-year extension of enhanced health insurance premium subsidies that are due to expire in January.

Senate Majority Leader John Thune (R-S.D.) controls the Senate floor schedule but promised to let Democrats have a vote on a proposal to extend the health insurance subsidies as part of a deal with centrist Democrats to reopen the federal government after a 43-day shutdown.

Schumer kept his plan close to the vest earlier in the week but said Thursday he expects every Democrat to vote for a straightforward three-year extension of the subsidies, which are provided through the Affordable Care Act (ACA).

“Senate Democrats will introduce legislation for a clean, three-year extension of the current ACA tax credits. This is the bill, a clean three-year extension of ACA tax credits that Democrats will bring to the floor of the Senate for a vote next Thursday, and every single Democrat will support it,” Schumer announced on the floor.

He said the vote will put pressure on Senate Republicans to vote to extend the subsidies in the absence of an alternative GOP proposal to address rising health care premiums.

“Republicans have one week to decide where they stand. Vote for this bill and bring health care costs down or block this bill and send premiums skyrocketing. That’s what’s at stake when we vote next week,” he said. “It’s going to be one of the most important votes we take.”

Senate Health, Education, Labor and Pensions Committee Chair Bill Cassidy (R-La.) has circulated a proposal to convert the enhanced premium subsidies under ObamaCare into federal contributions to health savings accounts that could be used to pay out-of-pocket health care costs.

Republican senators, however, say they haven’t seen the text of Cassidy’s bill yet and predict it won’t be ready for a vote on the floor next week.

Sen. Rick Scott (R-Fla.) has proposed using money that has funded the enhanced ACA subsidies to set up Trump Health Freedom Accounts that could be used to pay health insurance premiums for plans outside ObamaCare’s insurance marketplace.

 

Source Link

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square